238 related articles for article (PubMed ID: 34602490)
1. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
[TBL] [Abstract][Full Text] [Related]
2. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
3. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
4. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.
Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM
Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732
[TBL] [Abstract][Full Text] [Related]
5. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
[TBL] [Abstract][Full Text] [Related]
6. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
[TBL] [Abstract][Full Text] [Related]
8. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
Emmerson JT; Do Carmo S; Liu Y; Shalhoub A; Liu A; Bonomo Q; Malcolm JC; Breuillaud L; Cuello AC
Neurobiol Dis; 2023 Aug; 184():106227. PubMed ID: 37454780
[TBL] [Abstract][Full Text] [Related]
9. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
10. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
Mewes A; Franke H; Singer D
PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
[TBL] [Abstract][Full Text] [Related]
11. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.
Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M
Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267
[TBL] [Abstract][Full Text] [Related]
12. Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
Antón-Fernández A; Merchán-Rubira J; Avila J; Hernández F; DeFelipe J; Muñoz A
J Alzheimers Dis; 2017; 60(2):651-661. PubMed ID: 28922155
[TBL] [Abstract][Full Text] [Related]
13. The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies.
Goedert M
Alzheimers Dement; 2016 Oct; 12(10):1040-1050. PubMed ID: 27686274
[TBL] [Abstract][Full Text] [Related]
14. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model.
Wang W; Cao Q; Tan T; Yang F; Williams JB; Yan Z
Aging Cell; 2021 Oct; 20(10):e13456. PubMed ID: 34547169
[TBL] [Abstract][Full Text] [Related]
16. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
[TBL] [Abstract][Full Text] [Related]
17. Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Zaki MO; El-Desouky S; Elsherbiny DA; Salama M; Azab SS
Inflammopharmacology; 2022 Oct; 30(5):1871-1890. PubMed ID: 35922737
[TBL] [Abstract][Full Text] [Related]
18. Neuronal Spleen tyrosine kinase (SYK) mediates cytokine release in Transgenic Tau P301S mice organotypic brain slice cultures.
Schweig JE; Yao H; Jin C; Crawford F; Mullan M; Paris D
Neurosci Lett; 2020 Jun; 729():134992. PubMed ID: 32334108
[TBL] [Abstract][Full Text] [Related]
19. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
[TBL] [Abstract][Full Text] [Related]
20. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
